Inflammatory markers are used in the assessment of cancer and other chronic diseases. Inflammation markers raise in the inflammatory conditions.
This report contains market size and forecasts of Inflammatory Marker in Global, including the following market information:
Global Inflammatory Marker Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Inflammatory Marker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Interlukin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Inflammatory Marker include Merck, Novartis, Thermo Fisher Scientific, Cell Signaling Technology, Boditech Med, PHC Holdings, Abbott, Siemens and BG Medicine. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inflammatory Marker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inflammatory Marker Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Inflammatory Marker Market Segment Percentages, by Type, 2021 (%)
Interlukin
C Reactive Protein
Cellular Adhesion Molecule
Tumor Necrosis Factor-α
Others
Global Inflammatory Marker Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Inflammatory Marker Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Laboratories
Research Laboratories
Others
Global Inflammatory Marker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Inflammatory Marker Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inflammatory Marker revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Inflammatory Marker revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Novartis
Thermo Fisher Scientific
Cell Signaling Technology
Boditech Med
PHC Holdings
Abbott
Siemens
BG Medicine